Some studies have shown that urinary MCP-1 levels can be used to diagnose, assess the prognosis and treatment response of various inflammatory and non-inflammatory kidney diseases such as: IgA nephropathy, diabetic nephropathy, or polycystic kidney disease [145]. This evidence concerns the gene CCL2 and diabetic kidney disease.